Dantrolene reduces platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell proliferation and neointimal formation following vascular injury in mice
Dantrolene reduces platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell proliferation and neointimal formation following vascular injury in mice
复制标题
丹曲林可减少小鼠血管损伤后血小板衍生生长因子 (PDGF) 诱导的血管平滑肌细胞增殖和新内膜形成
DOI:
10.1016/j.bbrc.2022.07.038
复制
发表时间:
2022
影响因子:
3.1
通讯作者:
Yano Masafumi
中科院分区:
文献类型:
--
作者:
Sakai Chihiro;Mikawa Mei;Yamamoto Takeshi;Uchida Tomoyuki;Nakamura Yoshihide;Akase Hideaki;Suetomi Takeshi;Tominaga Naoomi;Inamitsu Masako;Oda Tetsuro;Okamura Takayuki;Kobayashi Shigeki;Yano Masafumi
Dantrolene is a ryanodine receptor blocker that is used clinically for treatment of malignant hyperthermia. This study was conducted using murine aortic vascular smooth muscle cells (MOVAS) and a mouse arterial injury model to investigate the inhibitory effect of dantrolene on smooth muscle cell proliferation and migration.We investigated whether dantrolene suppressed platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell proliferation and migrationin vitro. The effect of dantrolene on smooth muscle phenotype was evaluated using immunostaining. In addition, smooth muscle cell proliferation and phenotype switching were tested by applying dantrolene around blood vessels using a mouse arterial injury model. Dantrolene inhibited PDGF-induced cell proliferation and migration of MOVAS. Dantrolene also inhibited the switch from contractile to synthetic phenotype bothin vitroandin vivo.Dantrolene is effective at inhibiting vascular smooth muscle cell proliferation, migration, and neointimal formation following arterial injury in mice.